<DOC>
	<DOC>NCT01604044</DOC>
	<brief_summary>This study evaluates the effects of different therapies in ovulation induction in Intrauterine Insemination Cycles.</brief_summary>
	<brief_title>Highly Purified Menotropin (HP-hMG) Versus Recombinant FSH (rFSH) Plus Recombinant LH (rLH) in Intrauterine Insemination Cycles in Women ≥35 Years: a Prospective Randomized Trial.</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Infertility, Female</mesh_term>
	<criteria>women with story of infertility sine causa and mildmoderate male factor regular ovulatory menstrual cycles BMI ≤27 kg/m2 normal day 3 hormonal pattern bilateral tubal patency mono/bilateral tubal occlusion, severe male factor polycystic ovarian syndrome or any systemic disease or endocrine or metabolic abnormalities pelvic inflammatory disease endometriosis sexual organ malformations neoplasms or breast pathology incompatible with gonadotropin stimulation.</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>41 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>